Tilray Brands, Inc. (TLRY)
Tilray Brands, Inc. (TLRY) Beats Stock Market Upswing: What Investors Need to Know
In the latest trading session, Tilray Brands, Inc. (TLRY) closed at $0.61, marking a +1.21% move from the previous day.
Tilray Shares Blazing: What's Behind the 55% Rally This Month?
Tilray Brands Inc. NASDAQ: TLRY, once a leading light in the legal cannabis industry with shares trading as high as nearly $150, has seen its stock price almost entirely collapse in recent years. A multitude of factors may be to blame—the lack of federal legalization of recreational cannabis, regulatory inconsistencies, problems matching supply and demand, and more have all devastated the industry.
Tilray Brands, Inc. (TLRY) Declines More Than Market: Some Information for Investors
In the closing of the recent trading day, Tilray Brands, Inc. (TLRY) stood at $0.58, denoting a -8.88% move from the preceding trading day.
Tilray Brands: Gambling A Little Money Now Could Generate Sizable Future Payoff
Tilray Brands is a high-risk, high-reward opportunity after a 99%+ decline over seven years, now trading at deep value levels with minimal bankruptcy risk. The company is nearing profitability, with projected positive cash flow in 2025-26, marking a significant turnaround from years of losses. Potential U.S. regulatory changes under President Trump could dramatically boost industry sentiment and Tilray's prospects.
Here's Why Tilray Brands, Inc. (TLRY) Fell More Than Broader Market
In the most recent trading session, Tilray Brands, Inc. (TLRY) closed at $0.5, indicating a -6.55% shift from the previous trading day.
Tilray Brands, Inc. (TLRY) Stock Declines While Market Improves: Some Information for Investors
Tilray Brands, Inc. (TLRY) reached $0.4 at the closing of the latest trading day, reflecting a -2.84% change compared to its last close.
Why Tilray Brands, Inc. (TLRY) Dipped More Than Broader Market Today
Tilray Brands, Inc. (TLRY) closed at $0.38 in the latest trading session, marking a -9.07% move from the prior day.
Why Tilray Stock Plummeted by 26% in April
The marijuana sector, beset by a host of tough challenges, has been out of favor with investors for years. That looks unlikely to change as long as the drug remains illegal at the federal level, and even that might not save some of the market's players.
Tilray Brands Could Bounce Big
Tilray Brands missed Q3 expectations but improved its balance sheet, with net debt at $14 million. Despite revenue and EBITDA misses, Tilray's valuation is attractive, trading at 6.85X projected FY27 adjusted EBITDA, suggesting potential gains of up to 77%. Risks include NASDAQ delisting and integration challenges from numerous acquisitions, but maintaining the NASDAQ listing is crucial.
Tilray: Q3 Earnings Could Be The Inflection Point It Needs
Tilray's Q3 earnings show promising signs of improving fundamentals with expanding margins and effective cost management, combined with a clean balance sheet. Management's strategy shift to prioritizing profitable growth offers a viable path to long-term profitability. Despite improving fundamentals, Tilray appears to be undervalued, in my opinion.
Tilray Brands, Inc. (TLRY) Q3 2025 Earnings Call Transcript
Tilray Brands, Inc. (NASDAQ:TLRY ) Q3 2025 Earnings Conference Call April 8, 2025 8:30 AM ET Company Participants Berrin Noorata - Chief Corporate Affairs & Communications Officer Irwin Simon - Chairman & Chief Executive Officer Ty Gilmore - President, Tilray Beverages North America Carl Merton - Chief Financial Officer Denise Faltischek - Chief Strategy Officer & Head, International Jared Simon - President, Manitoba Harvest & Tilray Wellness at Manitoba Harvest Hemp Foods. Conference Call Participants Aaron Grey - Alliance Global Partners Victor Ma - TD Securities Frederico Gomes - ATB Capital Markets Pablo Zuanic - Zuanic & Associates Matt Bottomley - Canaccord Genuity Michael Lavery - Piper Sandler Operator Thank you for joining today's conference call to discuss Tilray Brands Financial Results for the fiscal 2025 third quarter ended February 28, 2025.
Tilray shares sink after quarterly revenue falls short of estimates
Tilray Inc (NASDAQ:TLRY) shares plunged more than 16% after the cannabis and consumer packaged goods-producer's fiscal third quarter financial report disappointed investors. Revenue fell year-over-year to $185.8 million from $188.3 million, well below expectations of $209.8 million.
